Heparan Sulfate in Prostate Cancer
硫酸乙酰肝素在前列腺癌中的作用
基本信息
- 批准号:10246930
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-13 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAdvanced DevelopmentAffectAnabolismBiochemicalBioinformaticsBiological AssayCXCR4 geneCancer Cell GrowthCancer EtiologyCancerousCell physiologyCell surfaceCellsCellular StructuresCessation of lifeCoupledDevelopmentDiseaseEXT1 geneEarly DiagnosisEnvironmentEnzymesEpithelial CellsEpitopesEventExtracellular MatrixFGF1 geneFGFR1 geneGene ExpressionGenesGeneticGrowthHeparitin SulfateHumanIL8RB geneIn VitroInfiltrationInflammationInflammatoryInvestigationKnock-outLifeLigandsMalignant NeoplasmsMalignant neoplasm of prostateMeasuresModelingMolecularMusMutateMyeloid-derived suppressor cellsPlayPolymersPolysaccharidesPrognosisProstateProstate Cancer therapyProstaticProteinsPublic HealthReportingRoleSignal TransductionSpecificitySpecimenStructureSystemTestingTumor Suppressor GenesXenograft procedureautocrinecancer initiationcell motilitychemokinein vivomenmouse modelneutralizing antibodynovelnovel markernovel therapeuticsoverexpressionprostate cancer cellprostate cancer cell lineprostate cancer modelpublic health relevancerecruittherapeutically effectivetumortumor progressiontumorigenesis
项目摘要
PROJECT SUMMARY
Prostate cancer (PCa) is one of the most prevalent forms of malignancy and the second most common cause of
cancer-related death in men. Uncovering novel mechanisms that control prostatic tumorigenesis may advance
development of more effective therapeutics to treat this life-threatening disease. Heparan sulfate (HS), a type of
polysaccharide, is an essential component of the cell microenvironment and plays an important role in cell-cell
and cell-matrix interaction and signaling. Recent studies reported that expression of HS-synthesizing and
modifying genes are dysregulated in human PCa specimens. Currently, it is not known what causes this
aberrant HS expression, and, more importantly, what are the functional consequences of the aberrant HS
expression in prostatic tumorigenesis. In this application, we propose to test our novel hypothesis “Pten-loss
in prostate leads to aberrant HS expression creating a unique cellular environment that potentiates
prostatic tumorigenesis” by pursuing the following three Specific Aims: 1. Determine if aberrant HS
expression in human prostate epithelial cells is induced by Pten-loss and correlates with malignancy of Pten-
null human PCa; 2. Determine if aberrant HS expression induced by Pten-loss potentiates prostatic
tumorigenesis; 3. Determine if aberrant HS expression induced by Pten-loss potentiates PCa-associated
inflammation. The proposed studies will use both novel and established genetic, cellular, biochemical and
bioinformatics approaches in conjunction with in vitro cell function and in vivo human and mouse PCa models.
These serial investigations are anticipated to delineate a novel mechanism that drives aberrant HS expression
in PCa, reveal the aberrant HS expression to be a novel biomarker for PCa early diagnosis and prognosis, and
elucidate the pivotal roles and their underlying molecular mechanisms of the aberrant HS expression in prostatic
tumorigenesis, which likely will contribute to the development of novel therapeutics for PCa treatment.
项目摘要
前列腺癌(PCA)是最普遍的恶性肿瘤形式之一,也是第二常见的原因
男性与癌症有关的死亡。发现控制前列腺肿瘤发生的新型机制可能会推进
开发更有效的治疗这种威胁生命的疾病的疗法。硫酸乙酰肝素(HS),一种类型
多糖是细胞微环境的重要组成部分,在细胞细胞中起重要作用
和细胞 - 矩阵相互作用和信号传导。最近的研究报告说,HS合成和
修饰基因在人PCA标本中失调。目前,尚不知道是什么原因造成的
异常HS表达,更重要的是,异常HS的功能后果是什么
前列腺肿瘤发生中的表达。在此应用中,我们建议测试我们的新假设“ PTEN-MLOSS
在前列腺中会导致异常的HS表达,从而创造出潜在的独特的蜂窝环境
前列腺肿瘤发生”通过追求以下三个特定目的:1。确定是否异常HS
人类前列腺上皮细胞中的表达是由PTEN损害诱导的,并且与PTEN-的恶性肿瘤相关
无人机PCA; 2。确定pten-loss诱导的异常HS表达是否增强了前列腺
3。确定PTEN-LOSS诱导的异常HS表达是否增强PCA相关
炎。拟议的研究将使用新颖和建立的遗传,细胞,生化和
生物信息学与体外细胞功能以及体内人类和小鼠PCA模型结合使用。
预计这些连续投资将描绘出一种新型机制,该机制驱动异常HS表达
在PCA中,揭示异常HS表达是PCA早期诊断和预后的新型生物标志物,并且
阐明前列腺异常HS表达的关键作用及其基本的分子机制
肿瘤发生,这可能有助于开发新的PCA治疗疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Houjian Cai其他文献
Houjian Cai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Houjian Cai', 18)}}的其他基金
Extracellular vesicles encapsulating CRISPR machinery for treatment of SARS-CoV-2 infection
封装 CRISPR 机制的细胞外囊泡用于治疗 SARS-CoV-2 感染
- 批准号:
10655147 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Blocking TMPRSS2 expression for prevention of SARS-CoV-2 infection
阻断 TMPRSS2 表达以预防 SARS-CoV-2 感染
- 批准号:
10303752 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Blocking TMPRSS2 expression for prevention of SARS-CoV-2 infection
阻断 TMPRSS2 表达以预防 SARS-CoV-2 感染
- 批准号:
10449301 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Targeting myristoylation of Src family kinases for inhibition of prostate tumorig
靶向 Src 家族激酶的肉豆蔻酰化抑制前列腺肿瘤
- 批准号:
8420668 - 财政年份:2013
- 资助金额:
-- - 项目类别:
Targeting myristoylation of Src family kinases for inhibition of prostate tumorig
靶向 Src 家族激酶的肉豆蔻酰化抑制前列腺肿瘤
- 批准号:
8675209 - 财政年份:2013
- 资助金额:
-- - 项目类别:
targeting myristoylation of Src family kinases for inhibition of prostate tumorig
靶向 Src 家族激酶的肉豆蔻酰化以抑制前列腺肿瘤
- 批准号:
8976526 - 财政年份:2013
- 资助金额:
-- - 项目类别:
Targeting myristoylation of Src family kinases for inhibition of prostate tumorig
靶向 Src 家族激酶的肉豆蔻酰化抑制前列腺肿瘤
- 批准号:
9298394 - 财政年份:2013
- 资助金额:
-- - 项目类别:
相似国自然基金
CTCF通过介导染色质高级结构调控非小细胞肺癌发生发展的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CTCF通过介导染色质高级结构调控非小细胞肺癌发生发展的机制研究
- 批准号:32100463
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
发展高级固体核磁方法探索功能材料的表界面化学
- 批准号:21922410
- 批准年份:2019
- 资助金额:120 万元
- 项目类别:优秀青年科学基金项目
TACSTD2在卵巢高级别浆液性癌发生发展中的作用及分子机制研究
- 批准号:81402157
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The role of RNA binding proteins in heart development and congenital heart defects
RNA结合蛋白在心脏发育和先天性心脏缺陷中的作用
- 批准号:
10827567 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
通过蛋白质精氨酸甲基化调节前列腺癌中的雄激素受体信号传导
- 批准号:
10584689 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Developing and Automating an Extracellular Vesicle-Based Test for Early Detection of Hepatocellular Carcinoma
开发和自动化基于细胞外囊泡的测试以早期检测肝细胞癌
- 批准号:
10823687 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Child and adult Metal exposures, gene expression and neuropathologically confirmed Alzheimer's Disease
儿童和成人金属暴露、基因表达和神经病理学证实的阿尔茨海默病
- 批准号:
10901032 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Dissecting the molecular regulation of T cell localization and function within the Mycobacterium tuberculosis granuloma
剖析结核分枝杆菌肉芽肿内 T 细胞定位和功能的分子调控
- 批准号:
10351422 - 财政年份:2022
- 资助金额:
-- - 项目类别: